[HTML] from plos.orgB Macadangdang, N Zhang, PE Lund, AH Marple… - PloS one, 2011 - dx.plos.org Peptide nucleic acid (PNA) is known to bind with extraordinarily high affinity and sequence-specificity to complementary nucleic acid sequences and can be used to suppress gene expression. However, effective delivery into cells is a major obstacle to the development of PNA for ... Related articles - Cached - All 4 versions
Y Zhou, J Agudelo, K Lu, DH Goetz, E Hansell… - Antiviral Research, 2011 - Elsevier Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have ...
[PDF] from puc.clAS Kondratowicz, NJ Lennemann… - Proceedings of the …, 2011 - National Acad Sciences ... eGFP) pseudotyped with either EBOV GP or VSV G (3). The EBOV GP that was used lacked the GP1 mucin domain (EBOV GP ΔO), as this form of GP confers the same tropism as full-length GP, contains the complete putative RBD, and produces higher pseudovirion titers (23 ... Cited by 4 - Related articles - All 4 versions
[HTML] from nih.govS Peng, B Ma, SH Chen, CF Hung… - Cell & bioscience, 2011 - ncbi.nlm.nih.gov ... the use of replication-defective human papillomavirus (HPV) pseudovirions as a novel approach to improve naked DNA vaccine delivery in vivo [1]. DNA plasmids can be packaged into the papillomavirus L1 and L2 capsid proteins to generate a 'pseudovirion' that can efficiently ...